| 000 | 01598nam a2200361Ia 4500 | ||
|---|---|---|---|
| 001 | 221533 | ||
| 003 | BIBL | ||
| 005 | 20210622062803.0 | ||
| 007 | ss lunjlu||||| | ||
| 008 | 980416s1997 gaunnn z l eng c | ||
| 035 | _a(OCoLC)37953344 | ||
| 037 | _bPromedica Research Center | ||
| 040 |
_aNLM _cNLM _dTML _dMNM _dNRM _dOCL |
||
| 042 | _apcc | ||
| 049 | _aPUXA | ||
| 060 | 0 | 0 |
_aWM 203 _bAC no.4 1997 |
| 069 | 0 | _a9803168 | |
| 090 |
_aRC514 _b.W6 1997 |
||
| 092 | _a610.73 | ||
| 245 | 0 | 0 |
_aWomen and schizophrenia _h[sound recording]. |
| 260 |
_aTucker, Ga. _bPromedica Research Center _c[1997] |
||
| 300 |
_a1 sound cassette _banalog _e1 guide (30 p.) |
||
| 306 | _a003600 | ||
| 500 | _aApproved for 1.8 contact hr. of CE credit by the Georgia Nurses Association. | ||
| 505 | 0 | _aIntroduction -- Epidemiological evidence of gender differences -- Neuroendocrine research -- Pharmacotherapy -- Non-pharmacological treatments. | |
| 508 | _aKathleen Jarboe. | ||
| 520 | _aFocuses on the specific issues surrounding the treatment and management of women with schizophrenia, discussing gender differences in schizophrenia including epidemiological evidence, brain morphology and neurodevelopment theories, the role of sex hormone dysregulation, and common gender-specific pharmacologic and psychosocial interventions for women with schizophrenia. | ||
| 650 | 0 |
_aSchizophrenia _2Local _9166071 |
|
| 650 | 0 |
_aNursing _9143898 |
|
| 650 | 0 |
_aWomen _xHealth and Hygiene. _2Local _948613 |
|
| 700 | 1 |
_aJarboe, Kathleen. _2Local _9116941 |
|
| 710 | 2 |
_aPromedica Research Center. _2Local _9154302 |
|
| 999 |
_c166064 _d166064 |
||